Variables | P value | OR (95% Cl) | I-square (%) | P for the heterogeneity |
---|---|---|---|---|
Cancer type | ||||
Prostate cancer (No.a: 10) | ||||
CC versus CA | 0.99 | 1.00 (0.87–1.15) | 49 | 0.05 |
CC versus AA | 0.51 | 0.94 (0.80–1.12) | 22 | 0.25 |
CA versus AA | 0.37 | 0.93 (0.79–1.09) | 0 | 0.85 |
CC versus CA+AA | 0.85 | 0.99 (0.85–1.14) | 56 | 0.02 |
CA versus CC+AA | 0.97 | 1.00 (0.91–1.09) | 36 | 0.13 |
AA versus CC+CA | 0.47 | 1.06 (0.91–1.23) | 0 | 0.54 |
C versus A | 0.55 | 0.97 (0.89–1.07) | 49 | 0.04 |
Renal cancer (No.a: 3) | ||||
CC versus CA | 0.35 | 1.21 (0.80–1.83) | 0 | 0.50 |
CC versus AA | 0.47 | 1.26 (0.67–2.36) | 0 | 0.83 |
CA versus AA | 0.94 | 0.99 (0.65–1.49) | 0 | 0.50 |
CC versus CA+AA | 0.30 | 1.23 (0.83–1.82) | 0 | 0.66 |
CA versus CC+AA | 0.40 | 0.87 (0.63–1.20) | 0 | 0.39 |
AA versus CC+CA | 0.98 | 1.00 (0.67–1.47) | 0 | 0.56 |
C versus A | 0.48 | 1.10 (0.85–1.41) | 0 | 0.55 |
Bladder cancer (No.a: 1) | ||||
CC versus CA | 0.30 | 0.79 (0.50–1.23) | NA | NA |
CC versus AA | 0.002 | 0.51 (0.33–0.78) | NA | NA |
CA versus AA | 0.004 | 0.64 (0.48–0.87) | NA | NA |
CC versus CA+AA | 0.02 | 0.62 (0.41–0.93) | NA | NA |
CA versus CC+AA | 0.04 | 0.74 (0.56–0.99) | NA | NA |
AA versus CC+CA | 0.0004 | 1.65 (1.25–2.19) | NA | NA |
C versus A | 0.00001 | 0.66 (0.54–0.82) | NA | NA |
Ethnicity | ||||
Asian (No.a: 4) | ||||
CC versus CA | 0.57 | 1.07 (0.84–1.37) | 0 | 0.44 |
CC versus AA | 0.70 | 0.91 (0.55–1.50) | 68 | 0.03 |
CA versus AA | 0.05 | 0.82 (0.68–1.00) | 40 | 0.17 |
CC versus CA+AA | 0.93 | 0.98 (0.66–1.46) | 58 | 0.07 |
CA versus CC+AA | 0.06 | 0.85 (0.71–1.01) | 0 | 0.58 |
AA versus CC+CA | 0.38 | 1.15 (0.84–1.58) | 66 | 0.03 |
C versus A | 0.61 | 0.93 (0.70–1.23) | 78 | 0.003 |
Caucasian (No.a: 7) | ||||
CC versus CA | 0.89 | 0.99 (0.86–1.13) | 52 | 0.06 |
CC versus AA | 0.31 | 0.87 (0.66–1.14) | 0 | 0.58 |
CA versus AA | 0.37 | 0.88 (0.66–1.16) | 0 | 0.75 |
CC versus CA+AA | 0.84 | 0.98 (0.80–1.20) | 53 | 0.06 |
CA versus CC+AA | 1.00 | 1.00 (0.82–1.22) | 49 | 0.08 |
AA versus CC+CA | 0.30 | 1.15 (0.88–1.51) | 0 | 0.70 |
C versus A | 0.31 | 0.96 (0.88–1.04) | 35 | 0.16 |